Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients

The Possible Role of Neuropeptide Y After Spontaneous Subarachnoid Hemorrhage

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01292278

Enrollment

Registered

2011-02-09

Start date

2006-01-31

Completion date

2016-12-31

Last updated

2014-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subarachnoid Hemorrhage

Keywords

subarachnoid hemorrhage, cerebral vasospasm, neuropeptide Y, spontaneous, aneurysmal

Brief summary

Neuropeptide Y (NPY) may play a major role in the pathophysiology of aneurysmal subarachnoid hemorrhage (aSAH). To investigate the correlation of NPY in cerebrospinal fluid (CSF) and blood (serum) and the neurological outcome in the acute stage of aSAH.

Detailed description

Evaluation of Neuropeptides in CSF and serum in SAH patients

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* spontaneous or aneurysmal subarachnoid hemorrhage

Exclusion criteria

* age younger than 18 years or older than 70 years * inflammatory disease * history of former SAH * no ventricular drainage

Design outcomes

Primary

Measure	Time frame
Glasgow Outcome Scale	2011-2016

Countries

Germany

Outcome results